Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/28/1996 | CA2219479A1 Methods of treatment and diagnostic visualisation, particularly in cancer |
11/28/1996 | CA2219121A1 A gene switch comprising an ecdysone receptor |
11/28/1996 | CA2218759A1 Novel variants of apolipoprotein a-i |
11/28/1996 | CA2218726A1 Methods for g protein coupled receptor activity screening |
11/27/1996 | EP0744467A2 Multiple antigenic peptide comprising at least two hepatitis C virus-associated peptides |
11/27/1996 | EP0744409A1 Platelet growth accelerator |
11/27/1996 | EP0744408A2 Rhesus ob protein and DNA |
11/27/1996 | EP0744027A1 Hydrophilic signal oligopeptides and methods of therapeutic use |
11/27/1996 | EP0743986A1 Heterologous dimeric proteins produced in heterokaryons |
11/27/1996 | EP0743984A1 Nucleic acid-containing composition, its preparation and use |
11/27/1996 | EP0743983A1 Mammalian thymokine genes |
11/27/1996 | EP0743982A1 Immortalized human fetal osteoblastic cells |
11/27/1996 | EP0743958A1 Non-viral vector |
11/27/1996 | EP0743957A1 Plasma concentrate and tissue sealant compositions |
11/27/1996 | EP0743956A1 Pretargeting methods and compounds |
11/27/1996 | EP0743955A1 Nerve growth factor structural analogs and their uses |
11/27/1996 | EP0743954A1 Methods for variation of chromatin condensation |
11/27/1996 | EP0743861A1 Radiolabeled annexins |
11/27/1996 | EP0495939B1 Sequential c-terminal degradation of peptides and proteins |
11/27/1996 | EP0491867B1 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
11/27/1996 | EP0446361B1 Polypeptide, production thereof, and pharmaceutical composition and cosmetic containing said polypeptide |
11/27/1996 | CN1136826A Recombinant P53 adenovirus method and compositions |
11/27/1996 | CN1136813A Novel synthetic peptide, lung surfactant containing the same and remedy for respiratory distress syndrome |
11/27/1996 | CN1136779A Long-acting injection suspensions and process for their preparation |
11/27/1996 | CN1136778A Sperm antigen corresponding to sperm zone binding protein autoantigenic epitope |
11/27/1996 | CN1136777A Immunomodulating compositions from bile |
11/27/1996 | CA2177328A1 Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor |
11/26/1996 | US5578715 Methods, kits, and probes for diagnosing HIV-2 |
11/26/1996 | US5578714 DNA encoding Duffy 9pd protein |
11/26/1996 | US5578710 Peptides and genetic engineering |
11/26/1996 | US5578708 Derived from bones of mammals including mice and humans; diagnosis and therapy for bone metabolic diseases |
11/26/1996 | US5578707 Soluble interferon-gamma receptor fragment |
11/26/1996 | US5578705 Cytoplasmic antiproteinase-2 coding sequences |
11/26/1996 | US5578704 Bone disorders |
11/26/1996 | US5578703 Dimer proteins which bind to transforming growth factor |
11/26/1996 | US5578702 Toxin active against lepidopteran insects |
11/26/1996 | US5578701 ppRB110 - nuclear phosphoprotein - the retinoblastoma susceptibility gene product |
11/26/1996 | US5578572 Anti-gram-positive bacterial methods and materials |
11/26/1996 | US5578569 Method of increasing bone growth |
11/26/1996 | US5578567 Nasal pharmaceutical composition |
11/26/1996 | US5578566 KGF receptor-derived antagonists of KGF binding |
11/26/1996 | US5578565 Reconstituted platelet membrane vesicles |
11/26/1996 | US5578564 Nickel-free hemoglobin and methods for producing such hemoglobin |
11/26/1996 | US5578500 Reagents and methods for the quantification of imipramine or desipramine in biological fluids |
11/26/1996 | US5578496 Detection of autoantibodies associated with the disease myasthenia gravis |
11/26/1996 | US5578483 Receptor transcription-repression activity compositions and methods |
11/26/1996 | US5578482 Ligand growth factors that bind to the erbB-2 receptor protein and induce cellular responses |
11/26/1996 | US5578479 Alpha-amylase from hyperthermophilic archaebacterium |
11/26/1996 | US5578478 Recombinant DNA encoding a desulfurization biocatalyst |
11/26/1996 | US5578475 Composition and methods for transfecting eukaryotic cells |
11/26/1996 | US5578473 Recombinant negative strand RNA virus |
11/26/1996 | US5578466 Recombinant co-expression system of protein disulfide isomerase gene, yeast receptor protein ERD2 gene and a foreign product polypeptide gene, and a process for producing the foreign polypeptide using such system |
11/26/1996 | US5578464 Proteins for gene expression with dna sequences |
11/26/1996 | US5578462 NF2 isoforms |
11/26/1996 | US5578461 Genetic engineering; amplification |
11/26/1996 | US5578456 Diagnosis of syphilis, antigen is protein from fusion of glutathione-s-transferase to membrane antigen |
11/26/1996 | US5578453 Cloning and expression of toxoplasma antigens and use of recombinant antigens |
11/26/1996 | US5578451 Detecting behavior toward amyloid precursor protein |
11/26/1996 | US5578448 Polymerase chain reaction |
11/26/1996 | US5578444 Sequence-directed DNA-binding molecules compositions and methods |
11/26/1996 | US5578323 Proteinoid carriers and methods for preparation and use thereof |
11/26/1996 | US5578309 For the treatment of candidiasis |
11/26/1996 | US5578308 Glutaraldehyde and formalin detoxified bordetella toxin vaccine |
11/26/1996 | US5578303 Vaccines, t-cells with specificity for heat shock protein 65 |
11/26/1996 | CA2076347C Improved antibody-enzyme direct conjugates and method of making same |
11/26/1996 | CA2069906C Uncharged morpholino-based polymers having achiral intersubunit linkages |
11/26/1996 | CA2033448C Antiherpes compositions and method of use |
11/21/1996 | WO1996036881A2 Screening for inhibitors of tcr-mhc interactions |
11/21/1996 | WO1996036738A1 Inhibition of immune responses by paramyxovirus |
11/21/1996 | WO1996036730A1 Cell death protein |
11/21/1996 | WO1996036722A2 Embedded expression of heterologous proteins |
11/21/1996 | WO1996036721A1 Promoters for gene expression |
11/21/1996 | WO1996036720A1 Recombinant heregulins and their biological functions upon receptor activation |
11/21/1996 | WO1996036715A1 A method and nucleotide sequence for transforming microorganisms |
11/21/1996 | WO1996036713A2 Eck receptor ligands |
11/21/1996 | WO1996036712A1 Recombinant baculovirus insecticides |
11/21/1996 | WO1996036711A2 Islet-specific homeoprotein and transcriptional regulator of insulin gene expression |
11/21/1996 | WO1996036710A1 Bmp-15 compositions |
11/21/1996 | WO1996036709A1 Transforming growth factor alpha hii |
11/21/1996 | WO1996036708A1 Autoantigen which can be used to detect a tendency to thrombosis |
11/21/1996 | WO1996036707A1 CANDIDA HEAT SHOCK PROTEIN, cDNA AND USES THEREOF |
11/21/1996 | WO1996036705A1 Viral vectors |
11/21/1996 | WO1996036702A2 Soluble, active hepatitis c virus protease |
11/21/1996 | WO1996036699A1 Non-pathogenic strains of hiv-1 and methods for detecting same |
11/21/1996 | WO1996036697A1 Transcriptional control sequences and methods |
11/21/1996 | WO1996036695A1 Ataxia-telangiectasia gene |
11/21/1996 | WO1996036691A1 Ataxia-telangiectasia gene and its genomic organization |
11/21/1996 | WO1996036645A1 Synthetic peptide analogs of cross-linked n-telopeptides of type i collagen |
11/21/1996 | WO1996036644A1 Obesity gene product |
11/21/1996 | WO1996036643A1 Method of inhibiting restenosis using calreticulin |
11/21/1996 | WO1996036642A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
11/21/1996 | WO1996036641A1 Susceptibility gene for obesity and type ii diabetes mellitus |
11/21/1996 | WO1996036366A1 Gene therapy for effector cell regulation |
11/21/1996 | WO1996036362A1 Compositions containing nucleic acids and ligands for therapeutic treatment |
11/21/1996 | WO1996036357A1 Carbohydrate-mediated coupling of peptides to immunoglobulins |
11/21/1996 | WO1996036355A1 Leptospira membrane proteins |
11/21/1996 | WO1996036354A2 Anticancer vaccine comprising il6/il6 receptor transfected cells |
11/21/1996 | WO1996036349A1 POST-TRANSLATIONAL ACTIVATION OF TGF-β1 INVOLVING THE TSP-1 RECEPTOR CD36 |
11/21/1996 | WO1996036221A2 Insect control with multiple toxins |
11/21/1996 | WO1996033414A3 Compounds and methods for diagnosis of leishmaniasis |